The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 376 participants.
Also called NCT04912167
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 376 participants
- Sponsor
- Registry
-
NCT04912167
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04912167. Randomized; single masking; primary purpose treatment. Start 2021-11 (anticipated); primary completion 2022-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial Infarction
- Acronym
- PERI-STEMI
- Condition
- STEMI
- Intervention (Drug)
- Sacubitril-Valsartan
- Intervention (Drug)
- Enalapril
- Intervention (Drug)
- Valsartan
- Lead sponsor
- West China Hospital
Record details
- Record id
cardio:ct-nct04912167- Content hash
a3334b7001bf7b9ed0ccb9d5c6239775680153db47f41868b2ec8e34891b17d1